Yaz FDA Approval History
FDA Approved: Yes (First approved March 16, 2006)
Brand name: Yaz
Generic name: drospirenone and ethinyl estradiol
Dosage form: Tablets
Company: Berlex, Inc.
Treatment for: Acne, Birth Control, Premenstrual Dysphoric Disorder
Yaz (drospirenone and ethinyl estradiol) is a combination oral contraceptive indicated for prevention of pregnancy in women who elect to use an oral contraceptive, treatment of symptoms of premenstrual dysphoric disorder and for the treatment of moderate acne vulgaris.
Development Timeline for Yaz
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.